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Platelet rich plasma (PRP) is defined as patient’s 
own blood product that consists a minimum of 
1,000,000/ μL of platelets and a high amount of seven 
growth factors including: epidermal growth factor 
(EGF), venous endothelial growth factor (VEGF), 
platelet-derived growth factor (PDGFaa, bb, ab) and 
transforming growth factor (TGFb1, b2). This product can 
accelerate cell proliferation, collagen formation and 
angiogenesis.  
PRP as layer in the graft site either by insertion or 
spray on (as a biomembrane) has been used in various 
oral and maxillofacial hard and soft tissue 
reconstructive and plastic surgeries (1). Notably, its 
bioconductive role should not be misinterpreted as 
bioinductive role by which stem cells are engaged. 
Marx, a pioneer in PRP, believes that PRP has 
remarkable outcomes when used with autogenous 
grafts and when applied with xenografts (2). According 
to similar concentration of fibronectin, vitronectin and 
fibrin in PRP to that of a clot, the use of PRP as 
bioadhesive with elimination of sutures has been a 
concern (1).  
Thrombocyte gel is prepared from blood and has 
lower and under optimal fracture and shear resistance 
when compared to other commercially available 
surgical adhesives (3). PRP was used successfully 
controlling bleeding in patients with cardiovascular 
diseases and anticoagulant medication (4). This 
promising evidence may aid the clinician for better 
bleeding diathesis vision, especially in the case of 
emergent surgeries of anticoagulated patients. There 
are clear evidences that PRP can be applied in 
reconstruction of jaw osseous defects, tooth root 
coverage with gingival, furcation involvement, 
lessening alveolar osteitis following tooth extractions, 
alveolar ridge augmentation, implant site augmentation 
in sinus lift surgery, augmenting bone-to-implant- 
contact (BIC), skin rejuvenation with fat injection, 
facial burn wound repair and reducing edema 
following impacted third molar surgical extraction or 
blepharoplasty (1, 2, 5). 
 
The preferable in-office method for PRP 
preparation is described with a dual-spin device (e.g., 
Harvest Tec.). The first spin (hard spin) extracts the red 
blood cells from the plasma which contains white 
blood cells WBC) and platelets.  
The second spin (soft spin) facilitates pulling 
platelets from WBCs. The traditional centrifuges and 
single spin devices are less successful to prepare an 
ideal solution in terms of high concentration of 
platelets and growth factors. Moreover, supplanting 
with calcium chloride and thrombin may increase the 
release of growth factors from α granule (Zymogen 
granules) (1, 2).  
Within 10 and 60 minutes after platelets being 
activated, 70% and 100% of growth factors are 
released, respectively. Surprisingly, production and 
release of such factors will be continued till platelets 
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death, by 8
th
 day of activation (1).
 
This unique product 
can be feasibly prepared bed-side within 30 minutes 
and is contrasted from other blood products in terms of 
being free form transmission of HCV, HIV, HBV and 
other blood-borne diseases. The application of such a 
product among the patients with localized or systemic 
diseases (head and neck radiotherapy or diabetes) that 
adversely affects the process of wound healing is 
recommended. When an extensive soft or hard tissue 
surgery is planned, PRP can be safely used to enhance 
the in-situ bleeding control, accelerate and improve 
angiogenesis and blood supply along with lowering the 
chance of scar formation by moderation of growth 
factors and fibroblasts activation (figure 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. Single spin device (A). Four milliliters blood was drawn and then mixed with 0.5 cc citrated sodium 
3.8%, then centrifuged at 460 g for 8 min.  a1: 1cc platelet poor plasma (PPP), 05μl of calcium chloride could be 
added to form membrane (glue). a2: 0.5 cc with moderate platelet count and growth factor (PGF), 25μl of 
calcium chloride is added to be mixed with osseous graft or other biomaterials. a3:  1cc platelet rich plasma 
(PRP), is used to be sprayed on implant surface, alveolar sockets and soft tissues (gel). b: white blood cell. c: red 
blood cell. (B) Patient presented with a large pyogenic granuloma (C), Large defect observed after the removal of 
lesion (D), a free gingival graft prepared from hard palate mucosa (E), bottom 1cc of PRP was removed and 
stored in a syringe (F) PRP sprayed at graft (G), graft was sutured over the defect (H) 
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